Search

Introduction: Advanced heart failure affects only a small percentage of patients with heart failure (HF), but never the less, is a growing public problem. Heart transplantation was a gold standard of treatment for many years, but in the last 10 years novel advanced treatment methods have become available as a therapy.1 Case report: In this case report we will show a 52 years old patient who was hospitalized in Department of Intensive Cardiac Care due to HF. Patient had biventricular dilative cardiomyopathy and had cachexia on admission. Because he was on inotropic support and his vital signs needed to be continuous monitoring, he needed intensified nursing care. His medical treatment was complicated with hemodynamic instability and eventually he underwent placement of veno-arterial extracorporeal membrane oxygenation, and 3 days after that he had been upgraded to central circulatory support of both ventricles. During that time, diagnostic workup for heart transplant was completed and he was listed for urgent heart transplant via „Eurotransplant”. After 20 days a suitable organ was offered, and he underwent the procedure with a good result during recovery. Conclusion: Medical care of patient with mechanical heart support is quite a challenge to nurses. However, her role is a crucial in multidisciplinary approach. Beside physical, educational and psychological help provided by nurse to a patient, she also coordinates work of the health team, navigates patient through the health system and allocates education and support for patient family members. Efficient team work with a focus on quality communication can significantly prevent work errors and can improve patient content with provided service. [ABSTRACT FROM AUTHOR]

Introduction: Mechanical circulatory support is becoming a more common therapy for end-stage heart failure in intensive cardiac care unit, and currently there are several types of devices that can be used as bridge therapy to recovery phase or hearth transplantation. Extracorporeal membrane oxygenation (ECMO) replaces heart and lung function using extracorporeal blood flow and it can be used as mechanical support in cardio-circulatory or respiratory failure.1 In a patient on ECMO support there is a strong activation of inflammatory response in a short period of time, usually due to shock before the initiation of support, but also, due to long, non-physiological blood flow through the piping, rotational pump and the oxygenator, where there is higher possibility of development of infection. In this phase patients are hemodynamically unstable, dependent on vasoactive support and substitution of intravenous fluids with a raise in inflammatory markers seen in laboratory results. Adsorbers for extracorporeal blood purification (CytosorbTM) can absorb molecules ranging from 5 to 55 kDa, which is the size where cytokines and some metabolites such as bilirubin, bile acids and ammonium can be absorbed, and it can be used to control inflammatory response which eventually can damage blood vessel walls and lead to target organs damage. Case report: This case report will show a 38-year-old patient who was hospitalized in Department of Cardiac Intensive Care after deterioration of his primary condition (cardiomyopathy) with hemodynamic instability, which lead to placement of both left and right sided mechanical circulatory support with an adsorber. This led to a decrease of inflammatory markers with good clinical and microbiological response. Patients soon underwent heart transplantation without any major complications and fast recovery. Conclusion: Use of adsorber via ECMO machine or dialysis machine is a very complex procedure which needs responsible approach to intervention and the only guarantee of success lays in a multidisciplinary approach. [ABSTRACT FROM AUTHOR]